PATRICK G. LEPORE - 13 Dec 2023 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Director
Signature
/s/ Mutya Harsch, attorney-in-fact for Patrick G. LePore
Issuer symbol
VYNE
Transactions as of
13 Dec 2023
Net transactions value
$0
Form type
4
Filing time
15 Dec 2023, 17:05:26 UTC
Previous filing
17 Nov 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VYNE Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 13 Dec 2023 Common Stock 20,000 $2.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date.